Highlights and Quick Summary
- Revenue for the quarter ending March 31, 2023 was $1.85 Million (a 4.99% increase compared to previous quarter)
- Year-over-year quarterly Revenue decreased by -36.41%
- Annual Revenue for 2022 was $26.9 Million (a 88.61% increase from previous year)
- Annual Revenue for 2021 was $14.3 Million (a -55.4% decrease from previous year)
- Annual Revenue for 2020 was $32 Million (a -64.74% decrease from previous year)
- Twelve month Revenue ending March 31, 2023 was $23.2 Million (a -13.61% decrease compared to previous quarter)
- Twelve month trailing Revenue decreased by -512.55% year-over-year
Trailing Revenue for the last four month:
| 31 Mar '23 | 31 Dec '22 | 30 Sep '22 | 30 Jun '22 |
|---|---|---|---|
| $23.2 Million | $26.9 Million | $7.75 Million | $-5.64 Million |
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Revenue of Precigen, Inc.
Most recent Revenueof PGEN including historical data for past 10 years.Interactive Chart of Revenue of Precigen, Inc.
Precigen, Inc. Revenue for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $1.85 | – | – | – | – |
| 2022 | $1.76 | $16.72 | $2.91 | $5.51 | $26.91 |
| 2021 | $-17.39 | $3.33 | $3.82 | $24.51 | $14.27 |
| 2020 | $-51.85 | $23.58 | $30.42 | $29.84 | $31.99 |
| 2019 | $17.0 | $18.3 | $32.84 | $22.59 | $90.72 |
| 2018 | $33.79 | $32.45 | $45.28 | $39.67 | $151.18 |
| 2017 | $65.27 | $46.02 | $54.43 | $53.75 | $219.46 |
| 2016 | $46.0 | $48.99 | $52.5 | $43.44 | $190.93 |
| 2015 | $41.5 | $53.37 | $44.89 | $33.85 | $173.61 |
| 2014 | $31.09 | $21.2 | $11.79 | $7.85 | $71.93 |
| 2013 | $7.14 | $6.04 | $6.69 | $3.89 | $23.76 |
| 2012 | $2.93 | $2.73 | – | – | $13.77 |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology